Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Schreiner Group Names Brian Zumbolo President | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Schreiner Group Names Brian Zumbolo President

Zumbolo brings expertise in developing new markets, acquisitions, and driving customer specifications.

By: Anthony Vecchione

Schreiner Group GmbH & Co. KG, a company that specializes in premium, functional labels enhanced by complementary system solutions and services, appointed Brian Zumbolo president of its U.S. plant in Blauvelt, NY.

Zumbolo previously worked at Schreiner in healthcare and mobility. Most recently he worked for a major supplier in the automotive industry. He has expertise in developing new markets, acquisitions, driving customer specifications, and in developing strong teams.

“Schreiner Group has performed very well in the U.S. over the past few years, now there is the opportunity to take the business to a new level of growth and expansion,” said Zumbolo. I believe Schreiner Group still has great market potential in the United States. In the future, I see our potential as equaling that of the Schreiner Group business in Europe.”

CEO Roland Schreinter said, I am pleased that we were able to attract such an experienced leader for our largest international facility so quickly,” said CEO Roland Schreiner. “With his experience and vision, Brian Zumbolo is a great asset to Schreiner Group.”


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters